TrialBritish journal of cancer2017

First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial.

Riccardo Giampieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.